206 related articles for article (PubMed ID: 20596476)
21. Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy study.
Kang W; Svirskis D; Sarojini V; McGregor AL; Bevitt J; Wu Z
Oncotarget; 2017 May; 8(22):36614-36627. PubMed ID: 28402271
[TBL] [Abstract][Full Text] [Related]
22. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
23. Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
Coderre JA; Elowitz EH; Chadha M; Bergland R; Capala J; Joel DD; Liu HB; Slatkin DN; Chanana AD
J Neurooncol; 1997 May; 33(1-2):141-52. PubMed ID: 9151231
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
25. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
26. Engineering Novel Targeted Boron-10-Enriched Theranostic Nanomedicine to Combat against Murine Brain Tumors via MR Imaging-Guided Boron Neutron Capture Therapy.
Kuthala N; Vankayala R; Li YN; Chiang CS; Hwang KC
Adv Mater; 2017 Aug; 29(31):. PubMed ID: 28620939
[TBL] [Abstract][Full Text] [Related]
27. Boron neutron capture therapy for malignant brain tumors.
Miyatake SI; Wanibuchi M; Hu N; Ono K
J Neurooncol; 2020 Aug; 149(1):1-11. PubMed ID: 32676954
[TBL] [Abstract][Full Text] [Related]
28. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
29. Boron Neutron Capture Therapy for Recurrent Glioblastoma Multiforme: Imaging Evaluation of a Case With Long-Term Local Control and Survival.
Shimizu S; Nakai K; Li Y; Mizumoto M; Kumada H; Ishikawa E; Yamamoto T; Matsumura A; Sakurai H
Cureus; 2023 Jan; 15(1):e33898. PubMed ID: 36819302
[TBL] [Abstract][Full Text] [Related]
30. Nonclinical pharmacodynamics of boron neutron capture therapy using direct intratumoral administration of a folate receptor targeting novel boron carrier.
Tsujino K; Kashiwagi H; Nishimura K; Fujikawa Y; Kayama R; Fukuo Y; Hiramatsu R; Nonoguchi N; Takata T; Tanaka H; Suzuki M; Hu N; Ono K; Wanibuchi M; Nakai K; Nakamura H; Kawabata S
Neurooncol Adv; 2024; 6(1):vdae062. PubMed ID: 38770220
[TBL] [Abstract][Full Text] [Related]
31. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
32. Bispecific antibodies as targeting agents for boron neutron capture therapy of brain tumors.
Liu L; Barth RF; Adams DM; Soloway AH; Reisfeld RA
J Hematother; 1995 Oct; 4(5):477-83. PubMed ID: 8581388
[TBL] [Abstract][Full Text] [Related]
33. A Boron-10 nitride nanosheet for combinational boron neutron capture therapy and chemotherapy of tumor.
Li L; Dai K; Li J; Shi Y; Zhang Z; Liu T; Jun Xie ; Ruiping Zhang ; Liu Z
Biomaterials; 2021 Jan; 268():120587. PubMed ID: 33296793
[TBL] [Abstract][Full Text] [Related]
34. An Assessment of the Potential Use of BNNTs for Boron Neutron Capture Therapy.
Ferreira TH; Miranda MC; Rocha Z; Leal AS; Gomes DA; Sousa EMB
Nanomaterials (Basel); 2017 Apr; 7(4):. PubMed ID: 28417903
[TBL] [Abstract][Full Text] [Related]
35. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
36. Water-Soluble
Nakagawa F; Kawashima H; Morita T; Nakamura H
Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
[TBL] [Abstract][Full Text] [Related]
37. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
38. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research.
Perks CA; Mill AJ; Constantine G; Harrison KG; Gibson JA
Br J Radiol; 1988 Dec; 61(732):1115-26. PubMed ID: 3064858
[TBL] [Abstract][Full Text] [Related]
39. Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Nichols TL; Kabalka GW; Miller LF; Khan MK; Smith GT
Med Phys; 2002 Oct; 29(10):2351-8. PubMed ID: 12408309
[TBL] [Abstract][Full Text] [Related]
40. Boron neutron capture therapy for glioblastoma: improvement of boron biodistribution by hyaluronidase.
Haselsberger K; Radner H; Pendl G
Cancer Lett; 1998 Sep; 131(1):109-11. PubMed ID: 9839625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
